# Introduction

In 2006, Professor Shinya Yamanaka and his team at Kyoto University produced iPS cells, what they call "dream cells," and more than 16 years have passed since then. At the time, the discovery attracted much attention as Japan's first regenerative medicine. In 2012, Professor Yamanaka received the Nobel Prize in Physiology and Medicine. He successfully performed a transplant operation on a patient's body for the first time globally. Numerous types of research have been conducted since then.



On the other hand, there remain some challenges in iPS cells, such as cost, lack of data, and technical limitations. iPS Coin advances iPS cell research and provides a means to solve the remaining problems. In addition, this token allows patients to access various services, including medical services. On the other hand, it will enable pharmaceutical companies and research institutions to receive donations of medical iPS cells, accelerating the realization of various medical objectives.



With blockchain technology, this project enables the secure and efficient sharing of research data, treatment protocols, and patient information regarding iPS cells. In addition, the iPS Coin also supports researchers to access funding easily and expedite innovation.



Individuals, research institutions, medical institutions, and other commercial service providers collaborate to develop a platform and an ecosystem where value is shared, centring on iPS Coin. The project aims to realize a future, as soon as possible, where patients with intractable diseases can access transplant treatment using iPS cells. The project also aims to improve the overall medical standard by expediting the broad adoption of regenerative medicine therapies and developing novel treatments.

